The Schall Law Firm is investigating Erasca, Inc. for potential securities law violations after the company disclosed a patent infringement claim from Revolution Medicines related to its ERAS-0015 drug. This disclosure led to a 48.3% drop in Erasca's stock price on April 28, 2026. The investigation is examining whether Erasca issued false or misleading statements or failed to disclose important information to investors. Shareholders who suffered losses are encouraged to contact the law firm to discuss their rights and possibly join a class action lawsuit.
Victoria Hanrahan, a senior manager at Nokia Corporation, purchased a total of 44,682 shares on May 26 and May 28, 2026. The shares were acquired on the New York Stock Exchange at an average price of $15.81 per share. This transaction signals confide...
Victoria Hanrahan, a senior executive at Nokia, acquired a total of 44,682 Nokia shares on May 26 and May 28, 2026. The shares were purchased on the New York Stock Exchange at average prices of $16.02 and $15.60 respectively, with a combined average ...
Shibarium, the blockchain platform linked to Shiba Inu, saw a sharp increase in daily crypto transactions, reaching 7,220 on May 26, 2026, after months of staying below 1,000 transactions per day. This surge coincides with a broader crypto market rec...
Dogecoin (DOGE) is trading near a key long-term ascending support line around $0.105, a level that has marked previous market cycle lows in 2017, 2020, and 2026. This support line has historically acted as a base after sharp declines from cycle peaks...
Ethereum is trading just above $2,000, a key support level, but shows signs of weakness with fading spot market demand and ETF outflows. Major holders with 100,000+ ETH have increased their positions to 17.41 million ETH, the highest in nine weeks, s...
